24.06.2023 |
Scientific publications

Coagulation assays for assessing direct FXa inhibitor oral anticoagulant reversal effect

Factor Xa direct oral anticoagulants (Fxa-DOACs) require rapid reversal in patients with serious bleeding or prior to urgent surgery.

Related items

26.10.2026

News, Scientific publications

VarmX announces publication of non-clinical safety, toxicokinetic and pharmacodynamic data for VMX-C001 in Pharmaceutics
Key HighlightsThe peer-reviewed study, published in Pharmaceutics (MDPI), describes the non-clinical safety pharmacology, toxicokinetics and pharmacodynamics of VMX-C001 in rats and…
Read more

24.02.2026

News, Scientific publications

VarmX announces publication of sensitive coagulation assays to assess restoration of coagulation using VMX-C001 in the presence of Factor Xa inhibitors
Key Highlights The collaborative study with Coagulation Profile BV, Maastricht University and Leiden University Medical Center has been accepted for…
Read more